Why the study?
Circulating omentin levels and visceral adipose-tissue mRNA expression differ across diabetes types, and the exact function and relative impact of fat-mass versus insulin-glucose metabolism remain unknown.
Does insulin-glucose metabolism and fat mass affect adipose omentin gene expression in diabetic C57BL/6 mice?
Does insulin-glucose metabolism and fat mass affect adipose omentin gene expression in diabetic C57BL/6 mice?
Omentin gene expression in adipose tissue is primarily regulated by insulin and glucose levels rather than fat mass in diabetic mouse models.
Answers are grounded in this paper and cite their sources.
Omentin expression differs by diabetes type in mice; leaves open whether insulin-glucose metabolism regulates omentin independently of obesity in humans.
Omentin, releasing by adipose-tissue may be related to glucose metabolism. The omentin circulating levels and the related mRNA expression in visceral adipose-tissue are different in types of diabetes and the exact function of this molecule is still unknown. The aim of this study was to examine omentin gene expression in adipose-tissues of type-1 and type-2 diabetic mice for the investigation of the effects of fat-mass and insulin–glucose metabolism. In this study, 36 C57BL/6 mice were divided into four experimental groups, including control, type-1 diabetes (inducted by streptozotocin), type-2 diabetes with obesity (high-fat diet + low-dose-streptozotocin [HFD + STZ]), and type-2 with normal weight (normal-pellet diet + low-dose-streptozotocin [NPD + STZ]). The present study involved the measurements of oral-glucose-tolerance-test and the levels of biochemical parameters, including blood glucose, omentin, insulin, lipid-profile, as well as aminotransferases. In addition, the omentin mRNA expression was evaluated by real-time polymerase-chain-reaction. The results of omentin gene expression analysis showed a significant difference between mRNA expressions in the experimental groups. The plasma omentin levels were significantly higher in type-1 diabetes group and lower in type-2 diabetes with NPD + STZ; however, the plasma omentin levels were not changed in the HFD + STZ group. In addition, the findings of serum-biochemical analysis revealed significant differences, compared to the control-group. The omentin expression may be affected by insulin and glucose levels in different types of diabetes more than fat-mass, and due to the local activity, the serum omentin may not comply with its gene expression.
No takes yet. Share an insight, caveat, or question.
Goodarzi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: